Lyell Immunopharma (LYEL) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to -$2.13.
- Lyell Immunopharma's EPS (Weighted Average and Diluted) rose 3879.31% to -$2.13 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.32, marking a year-over-year increase of 17083.89%. This contributed to the annual value of -$1.28 for FY2024, which is 3763.14% down from last year.
- Per Lyell Immunopharma's latest filing, its EPS (Weighted Average and Diluted) stood at -$2.13 for Q3 2025, which was up 3879.31% from -$2.89 recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's EPS (Weighted Average and Diluted) ranged from a high of -$0.03 in Q4 2022 and a low of -$3.59 during Q2 2024
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.27 (2023), whereas its average is -$1.05.
- Per our database at Business Quant, Lyell Immunopharma's EPS (Weighted Average and Diluted) skyrocketed by 9386.57% in 2021 and then tumbled by 164000.0% in 2024.
- Over the past 5 years, Lyell Immunopharma's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.18 in 2021, then skyrocketed by 83.33% to -$0.03 in 2022, then tumbled by 566.67% to -$0.2 in 2023, then tumbled by 275.22% to -$0.75 in 2024, then plummeted by 183.83% to -$2.13 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$2.13 for Q3 2025, versus -$2.89 for Q2 2025 and -$0.18 for Q1 2025.